pI: 5.6928 |
Length (AA): 509 |
MW (Da): 56757 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 109 | 4h87 (A) | 0 | 250 | 30.00 | 0.083 | 0.68 | 0.173545 | 1.16 |
19 | 139 | 3vpy (A) | 9 | 135 | 26.00 | 0.24 | 0.9 | 0.445121 | -0.2 |
24 | 430 | 3i6u (A) | 90 | 500 | 30.00 | 0 | 1 | 1.03681 | 0.53 |
27 | 431 | 3i6u (A) | 93 | 501 | 47.00 | 0 | 1 | 1.27608 | -0.53 |
142 | 416 | 2y7j (A) | 18 | 291 | 37.00 | 0 | 1 | 1.01468 | -1.17 |
334 | 419 | 3fbv (A) | 897 | 983 | 26.00 | 0 | 0.53 | 0.518159 | -0.77 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128695)
Species | Accession | Gene Product |
---|---|---|
Candida albicans | CaO19.4002 | kinase involved in DNA repair |
Candida albicans | CaO19.11485 | kinase involved in DNA repair |
Candida albicans | CaO19.14198 | protein kinase |
Candida albicans | CaO19.6936 | protein kinase |
Caenorhabditis elegans | CELE_T08D2.7 | Protein T08D2.7 |
Caenorhabditis elegans | CELE_Y60A3A.12 | Protein CHK-2 |
Dictyostelium discoideum | DDB_G0293656 | FHA domain-containing protein |
Dictyostelium discoideum | DDB_G0280321 | FHA domain-containing protein |
Dictyostelium discoideum | DDB_G0281567 | FHA domain-containing protein |
Dictyostelium discoideum | DDB_G0285963 | FHA domain-containing protein |
Drosophila melanogaster | Dmel_CG10895 | loki |
Echinococcus granulosus | EgrG_000772000 | serine:threonine protein kinase Chk2 |
Echinococcus granulosus | EgrG_000826300 | calcium:calmodulin dependent protein kinase I |
Entamoeba histolytica | EHI_011510 | protein kinase, putative |
Entamoeba histolytica | EHI_014100 | protein kinase, putative |
Echinococcus multilocularis | EmuJ_000772000 | serine:threonine protein kinase Chk2 |
Echinococcus multilocularis | EmuJ_000826300 | calcium:calmodulin dependent protein kinase I |
Homo sapiens | ENSG00000183765 | checkpoint kinase 2 |
Mus musculus | ENSMUSG00000029521 | checkpoint kinase 2 |
Saccharomyces cerevisiae | YPL153C | Rad53p |
Saccharomyces cerevisiae | YDL101C | Dun1p |
Schistosoma japonicum | Sjp_0004230 | ko:K06641 serine/threonine-protein kinase Chk2, putative |
Schistosoma mansoni | Smp_171370 | serine/threonine protein kinase |
Schmidtea mediterranea | mk4.000295.07 | |
Schmidtea mediterranea | mk4.000295.08 | Serine/threonine-protein kinase Chk2 |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_Y60A3A.12 | Caenorhabditis elegans | embryonic lethal | wormbase |
YPL153C | Saccharomyces cerevisiae | inviable | yeastgenome |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | checkpoint kinase 2 | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Homo sapiens | Cyclin-dependent kinase 1/cyclin B1 | 297 aa | 26.4% | 299 aa | Compounds | References |
Rattus norvegicus | Mitogen-activated protein kinase 1 | 358 aa | 31.3% | 310 aa | Compounds | References |
Oryctolagus cuniculus | Cyclin-dependent kinase 4 | 189 aa | 35.0% | 157 aa | Compounds | References |
Sus scrofa | Glycogen synthase kinase 3 beta | 420 aa | 27.7% | 346 aa | Compounds | References |
Plasmodium falciparum (isolate 3D7) | Cell division control protein 2 homolog | 288 aa | 30.5% | 249 aa | Compounds | References |
Rattus norvegicus | Serine/threonine-protein kinase pim-3 | 326 aa | 29.5% | 268 aa | Compounds | References |
Rattus norvegicus | Cell division protein kinase 5 | 292 aa | 28.4% | 303 aa | Compounds | References |
Rattus norvegicus | MAP kinase p38 alpha | 360 aa | 27.9% | 308 aa | Compounds | References |
Patiria pectinifera | Cdc2 | 300 aa | 28.6% | 245 aa | Compounds | References |